The importance of cytochrome p450 monooxygenase CYP2D6 in palliative medicine

Mellar P. Davis, Jade Homsi

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.

Original languageEnglish (US)
Pages (from-to)442-451
Number of pages10
JournalSupportive Care in Cancer
Volume9
Issue number6
DOIs
StatePublished - Jan 1 2001

Fingerprint

Cytochrome P-450 CYP2D6
Mixed Function Oxygenases
Cytochrome P-450 Enzyme System
Enzymes
Drug Interactions
Individuality
Opioid Analgesics
Antidepressive Agents
Antipsychotic Agents
Pharmacokinetics
Pharmaceutical Preparations
Population
Genes
Palliative Medicine

Keywords

  • CYP2D6
  • Drug interactions
  • Drug metabolism
  • Ethnic differences
  • Palliative medicine
  • Pharmacokinetics

ASJC Scopus subject areas

  • Oncology

Cite this

The importance of cytochrome p450 monooxygenase CYP2D6 in palliative medicine. / Davis, Mellar P.; Homsi, Jade.

In: Supportive Care in Cancer, Vol. 9, No. 6, 01.01.2001, p. 442-451.

Research output: Contribution to journalReview article

@article{5a08ea9482584dbf99343f514c240ccc,
title = "The importance of cytochrome p450 monooxygenase CYP2D6 in palliative medicine",
abstract = "The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.",
keywords = "CYP2D6, Drug interactions, Drug metabolism, Ethnic differences, Palliative medicine, Pharmacokinetics",
author = "Davis, {Mellar P.} and Jade Homsi",
year = "2001",
month = "1",
day = "1",
doi = "10.1007/s005200000222",
language = "English (US)",
volume = "9",
pages = "442--451",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - The importance of cytochrome p450 monooxygenase CYP2D6 in palliative medicine

AU - Davis, Mellar P.

AU - Homsi, Jade

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.

AB - The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.

KW - CYP2D6

KW - Drug interactions

KW - Drug metabolism

KW - Ethnic differences

KW - Palliative medicine

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=0034855786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034855786&partnerID=8YFLogxK

U2 - 10.1007/s005200000222

DO - 10.1007/s005200000222

M3 - Review article

C2 - 11585271

AN - SCOPUS:0034855786

VL - 9

SP - 442

EP - 451

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 6

ER -